药物-Fc结合体CD388向流感病毒神经氨基酶,在小鼠中具有广泛的保护作用
Simon Döhrmann1, James Levin1, Jason N Cole1
1Cidara Therapeutics, San Diego, CA, USA.
Nature microbiology
|March 18, 2025
概括
一种名为CD388的新药提供了对A型和B型流感病毒的广泛保护. 这种药物-Fc结合物显示出强大的疗效和在所有人群中普遍预防流感的潜力.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 流感病毒迅速改变抗原,逃避免疫力,需要广泛的抗病毒药物.
- 持久的,普遍的流感保护对健康个人和高风险群体都至关重要.
研究的目的:
- 设计和临床前表征CD388,一种新型抗病毒药物-Fc合物 (DFC).
- 评估CD388的广谱活性,耐药性潜力和对流感病毒的疗效.
主要方法:
- CD388的设计是作为扎纳米维尔的多价值结合物,与人类IgG1 Fc域连接,以延长半衰期.
- 临床前的研究是在小鼠和Cynomolgus身上进行的.
- 在致命感染模型中评估了抗病毒活性,耐药性发展和疗效.
主要成果:
- 与单独使用扎纳米维尔相比,CD388显示出更好的抗病毒活性.
- 它表现出强大的,对抗流感A和B菌株的普遍活性,包括耐药菌株.
- 在致命的小鼠模型中观察到低耐药性潜力和显著的疗效.
结论:
- CD388具有作为A型和B型流感的普遍预防治疗的潜力.
- 它为健康和高风险人群提供了希望,有助于疫情准备.
相关概念视频
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...